Ceritinib

Ceritinib is a targeted cancer medication used mainly for treating certain types of lung cancer that have a specific genetic abnormality called ALK-positive non-small cell lung cancer. It works by blocking the activity of the ALK protein, which helps cancer cells grow and spread. By inhibiting this protein, ceritinib can slow or stop the progression of the tumor. It is typically taken orally as a pill and is used when other treatments have not been effective. While effective for some patients, it may cause side effects and requires careful medical supervision.